Loading...
Guest User
Welcome! Please login.
| IPO Listing At | NSE SME |
| SME IPO Issue Type | Book Build Issue |
| Total Issue Size | ₹77.49 Cr |
| Reserved for Market Maker | ₹7.75 Cr |
| Net Issue Size | ₹77.49 Cr |
| Fresh Issue | ₹69.74 Cr |
| Face Value | ₹10 Per Equity Share |
| Price Band | ₹128.00-135.00 per share |
| NSE Code | KRMAYURVED |
| Registrar | Skyline Financial Services Pvt.Ltd. |
| Lead Managers | NEXGEN Financial Solutions Pvt.Ltd. |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 2,000 shares · Multiples of 1,000 shares
Incorporated on 3 September 2019, KRM Ayurveda Ltd. is operating a network of hospitals and clinics across multiple cities in India as well as marked its presence in abroad through telemedicines consulting and sales.
They manufacture Ayurvedic products, herbal and botanical remedies, medicines, supplements and possibly skin care / wellness related items.
Presently, the company runs 6 (Six) Hospitals and 5 (Five) Clinics at different locations in the country.
Hospitals and Clinics are equipped with the following infrastructure & facilities:
Services:
As on December 31, 2025, the company have total of 443 employees operating under various departments.
Competitive Strengths:
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Capital Expenditure for Construction and Development of Telemedicine Operational Facilities | 13.67 |
| 2 | Purchase of CRM Software and Hardware Infrastructure | 1.42 |
| 3 | Human Resources | 5.44 |
| 4 | Repayment/Prepayment of loan | 12.50 |
| 5 | Working Capital Requirement | 22.90 |
| 6 | General Corporate Purposes | 10.00 |
| 7 | Issue Expenses | 11.57 |
| Total | 77.49 |
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 78.12 | 66.79 | 43.91 | 39.48 |
| Total Income | 48.65 | 76.95 | 67.57 | 89.38 |
| Profit After Tax | 8.14 | 12.10 | 3.41 | 7.60 |
| EBITDA | 12.83 | 19.11 | 7.34 | 11.03 |
| NET Worth | 36.13 | 23.88 | 11.78 | 8.37 |
| Reserves and Surplus | 20.61 | 23.73 | 11.63 | 8.22 |
| Total Borrowing | 25.07 | 31.20 | 23.18 | 19.87 |
| Amount in ₹ Crore | ||||
| KPI | Sep 30, 2025 | Mar 31, 2025 |
|---|---|---|
| ROE | 21.84% | 67.86% |
| ROCE | 21.84% | 43.33% |
| Debt / Equity | 0.69% | 1.31% |
| RoNW | 21.84% | 67.86% |
| PAT Margin | 16.83% | 15.80% |
| EBITDA Margin | 26.54% | 24.96% |
| Price to Book Value | 5.27 | 0.08 |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (₹) | 7.79 | 5.69 |
| P/E (x) | 17.32 | 23.73 |
| Promoter Holding | 92.16% | 67.28% |
| Market Cap | ₹287.02 Cr. | |
